Trends  |   Treatment   |   Technology

 LIVE ONLINE 17 November 2020

Pharma Integrates Speakers 2020

JOHN TSAI

Head of Global Drug Development, Chief Medical Officer

Novartis

SIR MENELAS (MENE) PANGALOS

Executive Vice President, BioPharmaceuticals R&D

AstraZeneca

ANDREW PLUMP

President, Research & Development

Takeda Pharmaceutical Company

RICCARDO ZACCONI

Founder

PTEN Research

HUGO FRY

Managing Director | Vice President

Sanofi UK | ABPI

MARK STEVENSON

Executive Vice President and Chief Operating Officer

Thermo Fisher Scientific

MATTHEW CLEMENTE

Vice President, Device Development, Device R&D

Novo Nordisk

EMMA SCEATS

Chief Executive Officer

Isogenica

DAVE TUDOR

Managing Director, Medicines Manufacturing Innovation Centre

CPI

STEVE BARR

Vice President Business Development

SK biotek

JIM FOX

VP & Site Director, PSC Ware Site

GlaxoSmithKline

FRANCESCO DE RUBERTIS

Co-founder and Partner

Medicxi

RACHEL MURPHY

Chief Executive Officer

Difrent

TREVOR JONES

Director

Arix Bioscience plc and e-Therapeutics plc

IAN MUIR

Director, Healthcare & Lifesciences

Innovate UK

RICHARD TORBETT

Chief Executive Officer

ABPI

PRIYA MANDE

Chief Operating Officer

PsiOxus Therapeutics

HASSAN CHAUDHURY

Digital Health Specialist | Healthcare UK

Department for International Trade

SIMON HIRST

Chief Executive Officer

Sygnature Discovery

JO PISANI

Strategic Advisor, Non Executive Director and Charity Trustee

CHRISTIAN JONES

Chief Commercial Officer

Nanoform

KIMBERLY SMITH

Senior Vice President, Head of Research & Development

ViiV Healthcare

SCOTT JOHNSTONE

Chief Executive Officer

Scottish Lifesciences Association

JOHN DAWSON

Chief Executive Officer

Oxford Biomedica

PATRICK SHORT

Co-founder and Chief Executive Officer

Sano Genetics

NAWAL ROY

Founder and Chief Executive Officer

Holmusk

FLIC GABBAY

Managing Partner

tranScrip

RON JORTNER

Managing Director & Trustee

Masthead Biosciences & Cambridge Rare Disease Network

MIKE REA

Strategic Innovation Advisor and Chief Executive Officer

Nanoform and IDEA Pharma

MARK MILTON-EDWARDS

Head of Health Solutions – Digital Health

TEVA Pharmaceuticals

JASON LACOMBE

Chief Executive Officer

Veratrak

MARTINO PICARDO

Chairman

Discovery Park

JOYDEEP SARKAR

Chief Analytics Officer

Holmusk

AMANDA SIMONS

Partner, Patent Attorney

J A Kemp LLP

DETLEF BEHRENS

Managing Director

Bay Pharma

BRIAN HENRY

Vice President, Global Head of Drug Product Design

Pfizer Worldwide Research and Development

JOE DE SOUSA

Senior Leader, Non-Exec Director and Independent Consultant

Melhor Consulting

KATHRYN SIMPSON

Business Consultant

Kathryn Simpson Consulting

VANESSA LEMARIE

Director of Business Development Life Sciences & Program Owner of Rare Disease Initiative

Ada Health

PETER LYFORD

Business Development Director

Porton Pharma Solutions

CLAIRE THOMPSON

Chief Executive Officer

Agility Life Sciences

MARK DUMAN

Managing Director & Assessor- Digital Health

BioMedical Catalyst, MD Healthcare Consultants & Innovate UK

ANDREW CARMODY

Chief Executive Officer

The Health Data Exchange

GRAHAM LEWIS

Partner, Patent Attorney

J A Kemp LLP

HELEN BARKER

Head of Pharmaceutical Development

Reneo Pharma

ALASTAIR FLORENCE

Director, Continuous Manufacturing and Advanced Crystallisation (CMAC) Research Hub

University of Strathclyde

ASHLEY HOWARD

EMEA Manager, APG Pharma Solutions

Applied Materials 

SAMUEL BARON

Director of R&D

SK biotek Ireland

ROMA MAGUIRE

Professor of Digital Health and Care

University of Strathclyde

JAGJIT SINGH SRAI

Head, Centre for International Manufacturing, Institute for Manufacturing

University of Cambridge

GEORGE CROOKS

Chief Executive Officer

Digital Health & Care Institute

ANTHONY DAY

Blockchain Partner, Global Business Services

IBM Ireland Limited

STUART NEEDLEMAN

Chief Commercial Officer

Piramal Pharma Solutions

SEAN BREEN

Head Public Private Partnerships and Science Policy

Takeda

STEVE ANDERSON

Chief Scientific Officer

Covance Drug Development

JON-PAUL SHERLOCK

Global Technology Strategy Director, MS&T

AstraZeneca

MICHELE LESUEUR

Business Unit Director, UK & Ireland

Bristol Myers Squibb

NICK SIREAU

Chair and Chief Executive Officer

AKU Society

DAVID HAWKINS

Founder and Chief Executive Officer

Remedium Capital

ALASTAIR COUPE

Drug Product Design, Pharmaceutical Sciences

Pfizer Ltd

PAUL TUNNAH

Founder and Chief Content Officer

pharmaphorum and Healthware Group

MIKE GIBSON

Chief Technical Officer

Sterling Pharma Solutions

TINA FLATAU

Chief Executive Officer

Biopharma Projects

ANDY DWYER

Ware Pilot Plant & Global Manufacturing Technology Director

GSK

Trends   |   Treatment   |   Technology

 LIVE ONLINE 17 November 2020